Skip to main content
Deutsches Ärzteblatt International logoLink to Deutsches Ärzteblatt International
letter
. 2016 Aug 8;113(31-32):539–540. doi: 10.3238/arztebl.2016.0539b

In Reply

Arthur Schmidt *, Karel Caca *
PMCID: PMC5012165  PMID: 27581508

Endoscopic vacuum therapy (EVT) is an effective approach to the treatment of chronic leakages, and for esophageal anastomotic failures. However, our review article focused on acute iatrogenic perforation after diagnostic or therapeutic endoscopy (2). In this setting, very few data exist with regard to EVT, as most of the available studies included mostly patients with postoperative leakages (3).

The “treatment advantage” mentioned by our correspondents for EVT compared with stenting has not been satisfactorily confirmed for acute perforation: the three studies are retrospective and included primarily postoperative anastomotic failures. The current position paper of the ESGE mentions EVT in the context of treating acute perforation, but it does not provide any concrete recommendations, and neither does it provide an algorithm (3). Usually relevant paraesophageal fluid accumulation does not occur in the acute setting, especially in patients with smaller defects, and therefore effective closure, rather than drainage, is the primary concern: clips (for smaller defects) and coated stents are two established and widely available procedures. The case series of 10 patients mentioned by Loske indicates great effectiveness of EVT for acute perforations too, but the case number seems too low to recommend the procedure generally as first-line therapy. Larger studies are required in this setting. The remaining foreign body in the case of over the scope clips is clinically not problematic since these are intended as long-term implants, and in case of (rare) complications, such as luminal obstruction, they can usually be removed by using a special instrument for cutting (4).

Footnotes

Conflict of interest statement

Dr. Schmidt has received lecture fees and study support (third-party funding) from Ovesco Endoscopy.

Prof. Caca has received lecture fees from Olympus, Cook, Boston Scientific, Ovesco, and G-Surg. He has received study support (third-party funding) from Ovesco und G-Surg.

References

  • 1.Mennigen R, Senninger N, Laukoetter MG. Novel treatment options for perforations of the upper gastrointestinal tract: endoscopic vacuum therapy and over-the-scope clips. World J Gastroenterol. 2014;20:7767–7776. doi: 10.3748/wjg.v20.i24.7767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Schmidt A, Fuchs KH, Caca K, Küllmer A, Meining A. The endoscopic treatment of iatrogenic gastrointestinal perforation. Dtsch Arztebl Int. 2016;113:121–128. doi: 10.3238/arztebl.2016.0121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Paspatis GA, Dumonceau J, Barthet M, et al. Diagnosis and management of iatrogenic endoscopic perforations: European Society of Gastrointestinal Endoscopy (ESGE) Positions Statement. Endoscopy. 2014:693–711. doi: 10.1055/s-0034-1377531. [DOI] [PubMed] [Google Scholar]
  • 4.Schmidt A, Riecken B, Damm M, et al. Endoscopic removal of over-the-scope clips using a novel cutting device: a retrospective case series. Endoscopy. 2014:762–766. doi: 10.1055/s-0034-1365493. [DOI] [PubMed] [Google Scholar]

Articles from Deutsches Ärzteblatt International are provided here courtesy of Deutscher Arzte-Verlag GmbH

RESOURCES